N/A
N=84
Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise
Muscle Damage
Bottom Line
View on ClinicalTrials.gov: NCT02076334 ↗Enrolled (actual)
84
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Maximal Voluntary Contraction (MVC) — 182.4; 198.7; 208; 186.4 Newton-meters
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Far Infrared Fabric (Other); Spandex (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of North Carolina, Chapel Hill
- Primary completion
- Aug 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Maximal Voluntary Contraction (MVC) |
182.4; 198.7; 208; 186.4 | — |
| SECONDARY Creatine Kinase |
140.6; 158.2; 181.2; 108.2; 277.1; 458.5 | — |
Summary
To examine the influence of compression garments manufactured with Far-Infrared technology on exercise performance during and after repeated eccentric isokinetic muscle actions of the leg extensors.
Eligibility Criteria
Inclusion Criteria
- Cohort of Adult Males & Females
- Participant is between the ages of 18-35
- Healthy, Recreationally Active (1-5 hours per week)
- Participant has provided written and dated informed consent to participate in the study
- Participant is apparently healthy and free from disease, as determined by a health history questionnaire
- Participant agrees to abstain from smoking, caffeine (4hrs prior), tobacco (24hrs prior), and alcohol (24 hrs) before testing days
- Participant agrees to abstain from exercise 24 hours prior to each testing visit and after 72 hours of the induced exercise damage
- Participant will refrain from the use of non-steroidal anti-inflammatory drugs (NSAIDs) and protein supplementation 24 hours before the exercise testing protocol, as well as for the 72 hour period following the exercise testing protocol.
Exclusion Criteria
- Participant is using, or has used one of the following dietary supplements within 12 weeks prior to enrollment: beta-alanine, creatine, taurine, or any supplemental antioxidants (Acai, pomegranate, beet juice).
- Participant is in, or has participated in another clinical trial within 6 weeks prior to enrollment
- Participant has a known allergy or sensitivity to test product (determined from health history questionnaire and consent form)
Data sourced from ClinicalTrials.gov (NCT02076334). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.